Calon Cardio-Technology Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Reverse Merger
  • (Announced)

  • Investors
  • 8

Calon Cardio-Technology General Information

Description

Developer of implantable micro blood pump designed for the treatment of chronic heart failure. The company's device boosts the heart's output, reduces the stress on the heart and can be implanted through minimally invasive surgical procedures, thereby enabling healthcare professionals to treat patients progressing through the spectrum of advancing heart failure.

Contact Information

Formerly Known As
Calon Cardio Technology, MC405
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1b Sandringham Park
  • Swansea SA6 8PW
  • Wales, United Kingdom
Primary Industry
Therapeutic Devices
Corporate Office
  • 1b Sandringham Park
  • Swansea SA6 8PW
  • Wales, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Calon Cardio-Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Reverse Merger 24-Aug-2023 Announced Clinical Trials - General
10. Later Stage VC 14-Feb-2022 Completed Clinical Trials - General
9. Later Stage VC 31-Oct-2018 Completed Clinical Trials - General
8. Later Stage VC (Series B) 16-Oct-2015 Completed Pre-Clinical Trials
7. Later Stage VC 14-Oct-2013 Completed Pre-Clinical Trials
6. Grant 14-Mar-2013 Completed Pre-Clinical Trials
5. Later Stage VC 29-Jan-2013 Completed Pre-Clinical Trials
4. Later Stage VC (Series B) 23-Feb-2012 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 31-Mar-2010 $1.51M $1.51M Completed Startup
2. Angel (individual) 01-Jan-2007 Completed Startup
To view Calon Cardio-Technology’s complete valuation and funding history, request access »

Calon Cardio-Technology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
B Preferred Ordinary
B Preferred Ordinary
B Preferred Ordinary
A Ordinary
C Ordinary
A Ordinary
A Ordinary
A Ordinary 147,109 $0.013535 $6.77 $6.77 1x $6.77 3.46%
A Ordinary 103,584 $0.013535 $6.81 $6.81 1x $6.81 2.44%
To view Calon Cardio-Technology’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Calon Cardio-Technology Patents

Calon Cardio-Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4709464-A1 A medical device, assembly and system Pending 30-Mar-2023
GB-202304715-D0 A medical device, assembly and system Pending 30-Mar-2023
GB-2628606-A A medical device, assembly and system Pending 30-Mar-2023
GB-2644598-A A medical device, assembly and system Pending 30-Mar-2023
WO-2024200754-A1 A medical device, assembly and system Inactive 30-Mar-2023 A61M60/232
To view Calon Cardio-Technology’s complete patent history, request access »

Calon Cardio-Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Calon Cardio-Technology Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Atlantis Ventures Venture Capital Minority
Swansea Innovations Venture Capital Minority
The Share Centre Corporation Minority
Wren Capital Angel Group Minority
Arrowfield Capital Angel Group Minority
You’re viewing 5 of 8 investors. Get the full list »

Calon Cardio-Technology FAQs

  • When was Calon Cardio-Technology founded?

    Calon Cardio-Technology was founded in 2007.

  • Where is Calon Cardio-Technology headquartered?

    Calon Cardio-Technology is headquartered in Swansea, United Kingdom.

  • What is the size of Calon Cardio-Technology?

    Calon Cardio-Technology has 19 total employees.

  • What industry is Calon Cardio-Technology in?

    Calon Cardio-Technology’s primary industry is Therapeutic Devices.

  • Is Calon Cardio-Technology a private or public company?

    Calon Cardio-Technology is a Private company.

  • What is Calon Cardio-Technology’s current revenue?

    The current revenue for Calon Cardio-Technology is .

  • How much funding has Calon Cardio-Technology raised over time?

    Calon Cardio-Technology has raised $20.9M.

  • Who are Calon Cardio-Technology’s investors?

    New Atlantis Ventures, Swansea Innovations, The Share Centre, Wren Capital, and Arrowfield Capital are 5 of 8 investors who have invested in Calon Cardio-Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process